Diabetes Treatment Drugs Market, Global Outlook and Forecast 2023-2029

Report ID: MMG174971 | Category: Pharma & Healthcare | Pages: 68 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
This report aims to provide a comprehensive presentation of the global market for Diabetes Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Treatment Drugs. This report contains market size and forecasts of Diabetes Treatment Drugs in global, including the following market information:
Global Diabetes Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Treatment Drugs include Sanofi, Merck & Co., Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Novartis, Johnson & Johnson, AstraZeneca and Takeda, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
    Tablets
    GLP-1
    Insulin
Global Diabetes Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
    Type 1 Diabetes
    Type 2 Diabetes
Global Diabetes Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi
    Merck & Co.
    Novo Nordisk
    Eli Lilly
    Boehringer Ingelheim
    Novartis
    Johnson & Johnson
    AstraZeneca
    Takeda
    Bayer
    Tonghua DongBao
    Hua Dong
    Ganlee
    Biocon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Treatment Drugs, market overview.
Chapter 2: Global Diabetes Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Diabetes Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Diabetes Treatment Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Diabetes Treatment Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Diabetes Treatment Drugs Overall Market Size
    2.1 Global Diabetes Treatment Drugs Market Size: 2022 VS 2029
    2.2 Global Diabetes Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Diabetes Treatment Drugs Players in Global Market
    3.2 Top Global Diabetes Treatment Drugs Companies Ranked by Revenue
    3.3 Global Diabetes Treatment Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Diabetes Treatment Drugs Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Diabetes Treatment Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Diabetes Treatment Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Diabetes Treatment Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Diabetes Treatment Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Diabetes Treatment Drugs Market Size Markets, 2022 & 2029
        4.1.2 Tablets
        4.1.3 GLP-1
        4.1.4 Insulin
    4.2 By Type - Global Diabetes Treatment Drugs Revenue & Forecasts
        4.2.1 By Type - Global Diabetes Treatment Drugs Revenue, 2018-2023
        4.2.2 By Type - Global Diabetes Treatment Drugs Revenue, 2024-2029
        4.2.3 By Type - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Diabetes Treatment Drugs Market Size, 2022 & 2029
        5.1.2 Type 1 Diabetes
        5.1.3 Type 2 Diabetes
    5.2 By Application - Global Diabetes Treatment Drugs Revenue & Forecasts
        5.2.1 By Application - Global Diabetes Treatment Drugs Revenue, 2018-2023
        5.2.2 By Application - Global Diabetes Treatment Drugs Revenue, 2024-2029
        5.2.3 By Application - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Diabetes Treatment Drugs Market Size, 2022 & 2029
    6.2 By Region - Global Diabetes Treatment Drugs Revenue & Forecasts
        6.2.1 By Region - Global Diabetes Treatment Drugs Revenue, 2018-2023
        6.2.2 By Region - Global Diabetes Treatment Drugs Revenue, 2024-2029
        6.2.3 By Region - Global Diabetes Treatment Drugs Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Diabetes Treatment Drugs Revenue, 2018-2029
        6.3.2 US Diabetes Treatment Drugs Market Size, 2018-2029
        6.3.3 Canada Diabetes Treatment Drugs Market Size, 2018-2029
        6.3.4 Mexico Diabetes Treatment Drugs Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Diabetes Treatment Drugs Revenue, 2018-2029
        6.4.2 Germany Diabetes Treatment Drugs Market Size, 2018-2029
        6.4.3 France Diabetes Treatment Drugs Market Size, 2018-2029
        6.4.4 U.K. Diabetes Treatment Drugs Market Size, 2018-2029
        6.4.5 Italy Diabetes Treatment Drugs Market Size, 2018-2029
        6.4.6 Russia Diabetes Treatment Drugs Market Size, 2018-2029
        6.4.7 Nordic Countries Diabetes Treatment Drugs Market Size, 2018-2029
        6.4.8 Benelux Diabetes Treatment Drugs Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Diabetes Treatment Drugs Revenue, 2018-2029
        6.5.2 China Diabetes Treatment Drugs Market Size, 2018-2029
        6.5.3 Japan Diabetes Treatment Drugs Market Size, 2018-2029
        6.5.4 South Korea Diabetes Treatment Drugs Market Size, 2018-2029
        6.5.5 Southeast Asia Diabetes Treatment Drugs Market Size, 2018-2029
        6.5.6 India Diabetes Treatment Drugs Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Diabetes Treatment Drugs Revenue, 2018-2029
        6.6.2 Brazil Diabetes Treatment Drugs Market Size, 2018-2029
        6.6.3 Argentina Diabetes Treatment Drugs Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Diabetes Treatment Drugs Revenue, 2018-2029
        6.7.2 Turkey Diabetes Treatment Drugs Market Size, 2018-2029
        6.7.3 Israel Diabetes Treatment Drugs Market Size, 2018-2029
        6.7.4 Saudi Arabia Diabetes Treatment Drugs Market Size, 2018-2029
        6.7.5 UAE Diabetes Treatment Drugs Market Size, 2018-2029
7 Diabetes Treatment Drugs Companies Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Diabetes Treatment Drugs Major Product Offerings
        7.1.4 Sanofi Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.1.5 Sanofi Key News & Latest Developments
    7.2 Merck & Co.
        7.2.1 Merck & Co. Company Summary
        7.2.2 Merck & Co. Business Overview
        7.2.3 Merck & Co. Diabetes Treatment Drugs Major Product Offerings
        7.2.4 Merck & Co. Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.2.5 Merck & Co. Key News & Latest Developments
    7.3 Novo Nordisk
        7.3.1 Novo Nordisk Company Summary
        7.3.2 Novo Nordisk Business Overview
        7.3.3 Novo Nordisk Diabetes Treatment Drugs Major Product Offerings
        7.3.4 Novo Nordisk Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.3.5 Novo Nordisk Key News & Latest Developments
    7.4 Eli Lilly
        7.4.1 Eli Lilly Company Summary
        7.4.2 Eli Lilly Business Overview
        7.4.3 Eli Lilly Diabetes Treatment Drugs Major Product Offerings
        7.4.4 Eli Lilly Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.4.5 Eli Lilly Key News & Latest Developments
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Company Summary
        7.5.2 Boehringer Ingelheim Business Overview
        7.5.3 Boehringer Ingelheim Diabetes Treatment Drugs Major Product Offerings
        7.5.4 Boehringer Ingelheim Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.5.5 Boehringer Ingelheim Key News & Latest Developments
    7.6 Novartis
        7.6.1 Novartis Company Summary
        7.6.2 Novartis Business Overview
        7.6.3 Novartis Diabetes Treatment Drugs Major Product Offerings
        7.6.4 Novartis Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.6.5 Novartis Key News & Latest Developments
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Company Summary
        7.7.2 Johnson & Johnson Business Overview
        7.7.3 Johnson & Johnson Diabetes Treatment Drugs Major Product Offerings
        7.7.4 Johnson & Johnson Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.7.5 Johnson & Johnson Key News & Latest Developments
    7.8 AstraZeneca
        7.8.1 AstraZeneca Company Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Diabetes Treatment Drugs Major Product Offerings
        7.8.4 AstraZeneca Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.8.5 AstraZeneca Key News & Latest Developments
    7.9 Takeda
        7.9.1 Takeda Company Summary
        7.9.2 Takeda Business Overview
        7.9.3 Takeda Diabetes Treatment Drugs Major Product Offerings
        7.9.4 Takeda Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.9.5 Takeda Key News & Latest Developments
    7.10 Bayer
        7.10.1 Bayer Company Summary
        7.10.2 Bayer Business Overview
        7.10.3 Bayer Diabetes Treatment Drugs Major Product Offerings
        7.10.4 Bayer Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.10.5 Bayer Key News & Latest Developments
    7.11 Tonghua DongBao
        7.11.1 Tonghua DongBao Company Summary
        7.11.2 Tonghua DongBao Business Overview
        7.11.3 Tonghua DongBao Diabetes Treatment Drugs Major Product Offerings
        7.11.4 Tonghua DongBao Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.11.5 Tonghua DongBao Key News & Latest Developments
    7.12 Hua Dong
        7.12.1 Hua Dong Company Summary
        7.12.2 Hua Dong Business Overview
        7.12.3 Hua Dong Diabetes Treatment Drugs Major Product Offerings
        7.12.4 Hua Dong Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.12.5 Hua Dong Key News & Latest Developments
    7.13 Ganlee
        7.13.1 Ganlee Company Summary
        7.13.2 Ganlee Business Overview
        7.13.3 Ganlee Diabetes Treatment Drugs Major Product Offerings
        7.13.4 Ganlee Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.13.5 Ganlee Key News & Latest Developments
    7.14 Biocon
        7.14.1 Biocon Company Summary
        7.14.2 Biocon Business Overview
        7.14.3 Biocon Diabetes Treatment Drugs Major Product Offerings
        7.14.4 Biocon Diabetes Treatment Drugs Revenue in Global Market (2018-2023)
        7.14.5 Biocon Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Diabetes Treatment Drugs Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?